KPIL secured new orders worth ₹380 Crores in Q4 FY24, with year-to-date order inflows reaching ₹18,065 Crores
A day before its IPO opens for subscription, Sheetal Agarwal of IIFL caught up with management of the company.
Mankind Pharma stock has witnessed a nearly 20 % increase in the last six months
According to PRIME's Pranav Haldea, insurance firms sold a net of ₹15,622 Crore.
Double digit growth expected in revenue, PAT.
The second interim dividend is scheduled to be paid to members on March 5, 2024
Revenue from operations grew by 3% to ₹6,595 crore compared to ₹6,423 crore in the corresponding period last year.
The collaboration aims to advance renewable energy projects both domestically and internationally
This action is taken as these securities have surpassed 95% of the market-wide position limit (MWPL), as reported by the NSE
The Board approved a second interim dividend of ₹4.50 per equity share
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
